Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acorda Therapeutics (NQ: ACOR )

0.6000 -0.0200 (-3.23%)
Streaming Delayed Price Updated: 11:56 AM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acorda Therapeutics

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Avinger (NASDAQ:AVGR) stock moved... 
Via Benzinga
Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
From Acorda Therapeutics, Inc.
Via Business Wire
John Varian Joins Acorda Therapeutics Board of Directors
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RA... 
Via Benzinga
Acorda Inks Distribution Pact In Germany For Inhaled Levodopa Powder; Q3 Earnings Beat Expectations
Acorda Therapeutics Inc (NASDAQ: ACOR) entered into distribution and supply agreements with Esteve Pharmaceuticals GmbH to commercialize Inbrija 33 mg (... 
Via Benzinga
Topics Earnings
Exposures Financial
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. T2... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume for Molecular Templates's stock is 937.9K as... 
Via Benzinga
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
From Acorda Therapeutics, Inc.
Via Business Wire
Return on Capital Employed Insights for Acorda Therapeutics
After pulling data from Benzinga Pro it seems like during Q2, Acorda Therapeutics (NASDAQ:ACOR) posted sales of $31.79 million. Earnings were up 42.24%, but Acorda Therapeutics... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The company's market cap stands at $8.1 billion.... 
Via Benzinga
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
Acorda Therapeutics Reports Second Quarter 2021 Financial Results
From Acorda Therapeutics, Inc.
Via Business Wire
Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
From Acorda Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... 
Via Benzinga
40 Stocks Moving in Monday's Pre-Market Session
Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2... 
Via Benzinga
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers NanoVibronix (NASDAQ:NAOV) share... 
Via Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company Inc. (NYSE: NWHM) climbed 83% to $8.90 after the... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 56.69% to $5.97 during Friday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
Via Benzinga
Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med
Acorda Therapeutics Inc (NASDAQ: ACOR) has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A. to commercialize Inbrija 33... 
Via Benzinga
32 Stocks Moving in Friday's Pre-Market Session
Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported better-than-expected Q2 results. Acorda Therapeutics Inc (... 
Via Benzinga
12 Stocks Moving In Thursday's After-Hours Session
Gainers Twitter (NYSE: TWTR) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 sales guidance above estimates.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO... 
Via Benzinga
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
From Acorda Therapeutics, Inc.
Via Business Wire
34 Stocks Moving In Thursday's Mid-Day Session
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration statement in connect with the proposed merger... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.